<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Bayesian Semiparametric Causal Inference: Targeted Doubly Robust Estimation of Treatment Effects - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel Bayesian semiparametric methodology for estimating the average treatment effect (ATE) from high-dimensional observational data wit">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Bayesian Semiparametric Causal Inference: Targeted Doubly Robust Estimation of Treatment Effects</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.15904v1" target="_blank">2511.15904v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-19
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> G√∂zde Sert, Abhishek Chakrabortty, Anirban Bhattacharya
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> stat.ME, econ.EM, math.ST, stat.ML
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.15904v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.15904v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel Bayesian semiparametric methodology for estimating the average treatment effect (ATE) from high-dimensional observational data within the potential outcomes framework. It achieves this through a Bayesian debiasing procedure and targeted modeling based on debiased summary statistics, which, combined with sample splitting, ensures robustness and asymptotic efficiency.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This method is highly relevant for medicine as it provides a robust and efficient statistical tool to estimate the effectiveness of treatments and interventions from real-world observational patient data, especially where complex patient characteristics are high-dimensional and traditional randomized controlled trials are impractical.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This methodology can serve as a crucial statistical backbone for medical AI applications that aim to infer causal relationships from large, observational health datasets. AI models often struggle with confounding and correlation vs. causation. By providing a 'doubly robust' and 'targeted' method for estimating treatment effects, it enables AI systems to: 1) develop more reliable evidence-based treatment recommendations; 2) evaluate the effectiveness of health interventions and policies in real-world settings; 3) power personalized medicine algorithms that predict individual responses to treatments by correctly accounting for complex confounders; and 4) enhance the trustworthiness and interpretability of AI in healthcare by moving beyond associative findings to causal insights.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Proposes a Bayesian semiparametric methodology for estimating the Average Treatment Effect (ATE) in observational studies with high-dimensional nuisance parameters.</li>
                    
                    <li>Introduces a Bayesian debiasing procedure to correct for bias arising from the estimation of nuisance parameters (e.g., propensity score, outcome regression).</li>
                    
                    <li>Employs a targeted modeling strategy that utilizes debiased summary statistics, rather than the full data, facilitating hierarchical learning of the ATE.</li>
                    
                    <li>Combines debiasing with sample splitting, which separates nuisance estimation from inference on the target parameter, thereby reducing sensitivity to nuisance model specification.</li>
                    
                    <li>Establishes theoretical guarantees: the marginal posterior for the ATE satisfies a Bernstein-von Mises theorem under correct nuisance model specification, ensuring asymptotic efficiency and frequentist validity.</li>
                    
                    <li>Achieves Bayesian double robustness, meaning the method remains consistent and robust even when only one of the two nuisance models is correctly specified.</li>
                    
                    <li>Extensive simulations confirm the theoretical results, demonstrating accurate point estimation and credible intervals with nominal coverage in high-dimensional settings.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The paper develops a Bayesian semiparametric approach for causal inference. It utilizes the potential outcomes framework and incorporates a Bayesian debiasing procedure to correct for estimation bias from high-dimensional nuisance parameters. A targeted modeling strategy based on debiased summary statistics is employed, alongside sample splitting, to separate nuisance estimation from inference on the ATE. This ensures robust and efficient estimation.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study demonstrates that its proposed Bayesian method for ATE estimation exhibits robust theoretical properties, including satisfying a Bernstein-von Mises theorem under correct nuisance model specification for asymptotic efficiency and frequentist validity. Critically, it achieves Bayesian double robustness, maintaining consistency and robustness even if only one nuisance model is correctly specified. These theoretical results are strongly supported by extensive simulations showing accurate point estimation and nominal credible interval coverage in high-dimensional scenarios.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This methodology offers significant clinical impact by enabling more reliable and accurate estimation of treatment effects from complex real-world observational data, such as electronic health records or administrative claims. This can lead to improved evidence-based decision-making for clinicians, more informed health policy, and better assessment of drug efficacy or intervention effectiveness when randomized trials are not feasible, thereby advancing personalized medicine and comparative effectiveness research.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract primarily highlights the strengths and robust performance of the method under specified conditions. It notes that the Bernstein-von Mises theorem holds when both nuisance models are correctly specified and that consistency/robustness (Bayesian double robustness) is achieved when at least one is correct. The abstract does not explicitly detail specific limitations or caveats of the proposed methodology beyond these conditions for optimal performance.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors suggest that the proposed framework can be extended to estimate other causal estimands beyond the ATE. Furthermore, they posit that its key principles offer a general foundation for advancing Bayesian semiparametric inference more broadly across various statistical applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Epidemiology</span>
                    
                    <span class="tag">Pharmacoepidemiology</span>
                    
                    <span class="tag">Health Economics</span>
                    
                    <span class="tag">Public Health Research</span>
                    
                    <span class="tag">Comparative Effectiveness Research</span>
                    
                    <span class="tag">Clinical Informatics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Bayesian inference</span>
                    
                    <span class="tag tag-keyword">Causal inference</span>
                    
                    <span class="tag tag-keyword">Average Treatment Effect (ATE)</span>
                    
                    <span class="tag tag-keyword">Semiparametric estimation</span>
                    
                    <span class="tag tag-keyword">Double robustness</span>
                    
                    <span class="tag tag-keyword">Debiasing</span>
                    
                    <span class="tag tag-keyword">Observational studies</span>
                    
                    <span class="tag tag-keyword">High-dimensional data</span>
                    
                    <span class="tag tag-keyword">Potential outcomes</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">We propose a semiparametric Bayesian methodology for estimating the average treatment effect (ATE) within the potential outcomes framework using observational data with high-dimensional nuisance parameters. Our method introduces a Bayesian debiasing procedure that corrects for bias arising from nuisance estimation and employs a targeted modeling strategy based on summary statistics rather than the full data. These summary statistics are identified in a debiased manner, enabling the estimation of nuisance bias via weighted observables and facilitating hierarchical learning of the ATE. By combining debiasing with sample splitting, our approach separates nuisance estimation from inference on the target parameter, reducing sensitivity to nuisance model specification. We establish that, under mild conditions, the marginal posterior for the ATE satisfies a Bernstein-von Mises theorem when both nuisance models are correctly specified and remains consistent and robust when only one is correct, achieving Bayesian double robustness. This ensures asymptotic efficiency and frequentist validity. Extensive simulations confirm the theoretical results, demonstrating accurate point estimation and credible intervals with nominal coverage, even in high-dimensional settings. The proposed framework can also be extended to other causal estimands, and its key principles offer a general foundation for advancing Bayesian semiparametric inference more broadly.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>48 pages (including supplement)</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>